Know Cancer

or
forgot password

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients


N/A
N/A
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients


Inclusion Criteria:



- non metastatic Prostate Cancer

- previous treatment with bicalutamide 150mg

- biochemical relapse/progression

Exclusion Criteria:

- use of other treatments for Prostate Cancer

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Retrospective

Outcome Measure:

Hormonal sensitivity to second line treatment for CaP after Bicalutamide

Outcome Time Frame:

six months

Safety Issue:

No

Principal Investigator

Davide Meani, MD

Investigator Role:

Study Director

Investigator Affiliation:

AstraZeneca Medical Dept

Authority:

Italy: Ethics Committee

Study ID:

NIS-OIT-CAS-2007/1

NCT ID:

NCT00668083

Start Date:

September 2007

Completion Date:

July 2008

Related Keywords:

  • Prostate Cancer
  • second line
  • Prostate Cancer
  • bicalutamide
  • biochemical relapse/progression in patients with Prostate Cancer treated with bicalutamide 150mg
  • Prostatic Neoplasms

Name

Location